Breaking News

QuantRx, KNH Join Forces

September 6, 2007

QuantRx Biomedical has entered into an agreement with KNH.

QuantRx Biomedical Corporation, Doylestown, PA, an emerging leader in the research and development of medical diagnostic platforms and products, has entered into a long-term agreement with nonwoven roll goods producer Kang Na Hsiung (KNH) of Taiwan. The partnership covers the process development, manufacturing and packaging of its PAD-based product line. KNH’s portfolio targets applications ranging from personal care, hygiene and skin care to industrial specialty products.

According to QuantRx, this milestone will allow the company to rapidly scale the production of its PAD technology products to meet anticipated demand and expanding market reach. This agreement includes its feminine hygiene products and enables QuantRx to seek marketing and distribution agreements with companies in Europe and Asia, and comfortably meet any additional demand.

"KNH has worked closely with us to assure the product is of a quality that will meet global consumer standards," said Bill Fleming, chief scientific officer of QuantRx. "Their support and expertise has been valuable in assuring quality products for our pending launches."

QuantRx anticipates the sale and distribution of its line of feminine hygiene pad products will have a positive impact on its revenue in 2008 and beyond.


Related Application:

  • The Year That Was 2016

    The Year That Was 2016

    Karen McIntyre, Editor||December 1, 2016
    The year 2016 included investments, new product development and an entrepreneurial spirit in nonwovens that will surely impac

  • An Assessment of the Global Feminine Care Market

    An Assessment of the Global Feminine Care Market

    November 7, 2016
    Buying trends of women in U.S., China, Mexico and Europe assesses buying preferences of san pro productsand new technologies.

  • WHO’S WHO IN SAN PRO MACHINERY

    November 7, 2016
    A listing of equipment suppliers to the global feminine hygiene market.